[Newborn infants of mothers with endocrinopathies].
When pregnancy and endocrinological disease evolve together, the course of the endocrinological disease and/or the pregnancy and/or the development of the fetus can be altered. Pathophysiological interactions and their therapeutic consequences are reviewed regarding 21-hydroxylase deficiency congenital adrenal hyperplasia, ovary and adrenal virilizing tumours, Addison disease, primary hyperaldosteronism, pheochromocytoma, Graves' disease, Hashimoto thyroiditis, primary hypothyroidism, primary hypo- and hyperparathyroidism and bromocriptine treatment of hyperprolactinaemia.
Ponte
C
C
Service de pédiatrie B, hôpital Calmette, Lille, France.
D000307:Adrenal Gland Diseases / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications; D004700:Endocrine System Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology*; D010051:Ovarian Neoplasms / Q000150:complications; D010279:Parathyroid Diseases / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications; D013959:Thyroid Diseases / Q000150:complications
Nouveau-nés de mères atteintes d'endocrinopathies.